BackMedTech Acquisition Overview

MedTech Acquisition Receivables

MedTech Acquisition's receivables is $6.5M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$6.46M
↑ 15.94% YoYΔ $888000.00 vs prior year quarter

Peer trimmed avg / median

Loading

MedTech Acquisition Receivables History

Loading

MedTech Acquisition vs. peers: Receivables Comparison

Loading

MedTech Acquisition Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

MedTech Acquisition (MTAC) FAQ

MedTech Acquisition (MTAC) currently reports a receivables of $6.5M as of June 2026. That compares with $5.6M in the prior-year period — up 15.9% year over year. Use the charts on this page to explore MedTech Acquisition's receivables history and peer comparisons.

MedTech Acquisition's receivables increased from $5.6M to $6.5M — a 15.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

MedTech Acquisition reported $6.5M in receivables as of June 2026. That compares with $5.6M in the prior-year period — up 15.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $6.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for MedTech Acquisition, and consider following MTAC for alerts when major investors trade the stock.